Viralab Inc.

Viralab Inc. is the exclusive U.S. distributor for Viramed Biotech AG (Munich, Germany), a leading manufacturer of immunoblot reagents and diagnostic products for clinical and research laboratories. Founded in 2003, Viralab specializes in high-quality laboratory reagents for infectious disease serology testing, with particular expertise in Lyme disease (Borrelia burgdorferi) confirmation and screening. Product portfolio includes ViraChip and ViraStripe immunoblot systems for Borrelia (Lyme), SARS-CoV-2, Bordetella pertussis, and Helicobacter pylori detection across multiple antibody classes (IgG, IgM, IgA). The Borrelia All-In-One ViraChip was FDA-cleared in August 2022, providing both screening and confirmation in a single 2.5-hour assay. Viralab operates a 24-hour ordering system with next-day delivery capability and telephone support Monday–Friday 8 a.m.–5 p.m. Central Time. The company maintains strong relationships with major clinical laboratory associations including AACC and AMLI, and regularly exhibits at Clinical Virology Symposium and related professional conferences.